about
Resolution of inflammation in asthmaDifficult asthmaEpithelial ciliated beating cells essential for ex vivo ALI culture growthRegulation of CXCR/IL-8 in human airway epithelial cells.Inflammatory features of nasal mucosa in smokers with and without COPD.Is generalization of exhaled CO assessment in primary care helpful for early diagnosis of COPD?Effects of inhaled corticosteroids on pathology in asthma and chronic obstructive pulmonary disease.5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors.Rhinovirus-associated pulmonary exacerbations show a lack of FEV1 improvement in children with cystic fibrosis.Upper airway x 1: allergic rhinitis and asthma: united disease through epithelial cells.Adherence in severe asthma.Bronchial epithelium as a target for innovative treatments in asthma.Safety and cellular assessment of bronchial brushing in airway diseases.Leptin and leptin receptor expression in asthma.Thiazolidinediones induce proliferation of human bronchial epithelial cells through the GPR40 receptor.Hospitalizations for COPD Exacerbations: Trends and Determinants of Death.Lipoxins and other arachidonate derived mediators in bronchial asthma.Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.Distal airway impairment in obese normoreactive women.Mild asthma in overweight women: A new phenotype?Disease activated drugs: a new concept for the treatment of asthma.Lipoxins are potential endogenous antiinflammatory mediators in asthma.Role of comorbid conditions in asthma hospitalizations in the south of France.Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma.Severe asthma in adults: what are the important questions?Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound.Nonlinear weight and chronic obstructive pulmonary disease effect modeling to improve data fitting.Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics.Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension.Expression of the high-affinity receptor for IgE on bronchial epithelial cells of asthmatics.Club cell secretory protein serum concentration is a surrogate marker of small-airway involvement in asthmatic patients.Supplementing defect in club cell secretory protein attenuates airway inflammation in COPD.Prognostic value of cluster analysis of severe asthma phenotypes.Airway lipoxin A4/formyl peptide receptor 2-lipoxin receptor levels in pediatric patients with severe asthma.Persistent severe hypereosinophilic asthma is not associated with airway remodeling.Glucocorticoid receptor-binding characteristics in severe asthma.Computed tomography quantification of airway remodelling in normal ageing subjects: a cross-sectional study.Corticosteroid-induced epithelial shedding in asthma.An ex vivo model of severe asthma using reconstituted human bronchial epithelium.Limited short-term steroid responsiveness is associated with thickening of bronchial basement membrane in severe asthma.
P50
Q26823724-97A44325-CF18-4ED1-9A04-1559CD50ECFEQ28200626-A90C4A2E-916D-40DA-9AC3-5BF83DAD551FQ29994850-6777DB48-0C5F-471C-9A77-940C19A00849Q33518986-02EBB4BE-C1A2-4B89-A343-CD3D9BA77706Q35573166-5416F4B4-7860-433B-AF2E-B19CBA9487D3Q35616872-E1245F8B-59D8-467A-96F7-7736E70B1CADQ36236852-DD0E10A4-FB0E-4B32-87DA-B6B191256C51Q36366468-9D79E45A-80C4-4A4C-83D7-C779500BBC2BQ36559766-BBBC7245-6B9D-4311-98CC-184B95AB3745Q37623276-990D834F-B016-4CC3-806A-816405DDD295Q38056182-1935B7EC-2892-4886-93D5-6A445FBD079DQ38123598-75B822F5-7CE4-45F6-8251-9DE192B97F05Q39516381-702A9D43-C873-4EE5-9281-CDD2B3D8BDBCQ39835935-10231F0C-2682-4B4B-9F82-1EE089FA849FQ39864024-F79B6789-30EE-4A30-B1BA-E72FDE22188BQ41493492-A5BDC8A9-3729-4818-9C6B-E7A0467EB31DQ41871817-DFD590FB-A7DD-4ACF-8397-C53A537BD291Q42213051-E3780634-E6D3-4643-85A3-4048C682D341Q42559407-53BA2C9E-C5B0-403F-B9C8-59AC653F92D1Q43110574-219FFAEF-0241-48A2-A4FC-642710F37D8EQ43653170-F0C357BF-DF98-4741-AD08-32CA4D1CEBFAQ44014996-393649C0-396E-455A-BB40-2BEB1FBFAF27Q44235707-C13F0A97-8A3D-43C3-B30B-3DE2628AAE8DQ44534195-729DFBA7-B423-4F0C-8BF1-57F28D16B4E1Q44683157-94877928-66D4-4613-A6F3-2FF4899BFFAAQ45215082-FF7F1993-E211-40A0-B528-0A084CE2106CQ45916772-5FCD914C-99E7-45FC-9AB1-F6A25A286459Q45926675-FF9DC317-692E-4347-B8F9-EEE5ADA819CFQ47556018-5734ACE7-FA7D-4FE7-94C6-1850A186E6C4Q47892870-59D3EF46-FF45-4AB7-8CB8-E9D523D86833Q47992951-90CF7B9F-5D0E-496B-B2D9-F37B6F1B749FQ51028054-03C4FFDC-8ABB-4E6C-8063-13889218AA20Q51071213-123440ED-6BD3-454A-B82A-2CC0AAED7207Q51540221-9B2C1C59-A2ED-44FD-A146-7A07859889BCQ51666556-C0830A27-DDCA-4449-9845-3246D8288A2FQ51668834-A7377C8E-AEAC-4B2E-927F-12BF9E1B90E1Q51672755-77E0D117-2F52-440B-B062-0BDC7B63072FQ51699397-6A5A6A1C-CCE7-48E0-B2D2-715D24976DC8Q51804752-26C239D7-F251-4957-BA97-8BA3906E4B18Q53187873-96A4F1DD-6CD8-47B3-9C95-05F5C8DCD657
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Isabelle Vachier
@ast
Isabelle Vachier
@en
Isabelle Vachier
@es
Isabelle Vachier
@nl
Isabelle Vachier
@sl
type
label
Isabelle Vachier
@ast
Isabelle Vachier
@en
Isabelle Vachier
@es
Isabelle Vachier
@nl
Isabelle Vachier
@sl
prefLabel
Isabelle Vachier
@ast
Isabelle Vachier
@en
Isabelle Vachier
@es
Isabelle Vachier
@nl
Isabelle Vachier
@sl
P106
P1153
7003854265
P21
P31
P496
0000-0003-2730-5165